Water Flossing Versus Dental Floss for Oral Hygiene in Children Aged 10-15 Years: A Randomized Trial

March 16, 2026 updated by: Shahad Abudawood, King Abdulaziz University

The Effectiveness of Water Flossing Versus Regular Flossing for Oral Hygiene in Children Aged 10-15 Years: A Randomized Clinical Trial

The goal of this Randomized Clinical Trial is to compare the effectiveness of water flossing versus regular flossing in reducing dental plaque in children aged 10-15 years. The main question is the water flossing equal or more effective than regular flossing. Each participant will use both interdental cleaning methods, water flossing and regular flossing, in two separate visits and the plaque Index (PI) will be recorded.

Regular Dental Floss Group: Unflavored, unwaxed regular dental floss (Oral-B, USA), or Water Flosser: Water flosser (Waterpik Cordless Plus Water Flosser, USA)

Study Overview

Detailed Description

Ethical Approval:

The study protocol was reviewed and approved by the Research Ethics Committee of the Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia. Written informed consent was obtained from all parents or legal guardians prior to participation, in accordance with the Declaration of Helsinki.

Study Design:

This study was designed as a randomized, controlled crossover clinical trial. Each participant used both interdental cleaning methods, water flossing and regular flossing, in two separate visits with a 14-day washout period between interventions to minimize carryover effects.

Study Setting:

The study was conducted at the College of Dentistry and the University Dental Hospital, King Abdulaziz University, Jeddah, Saudi Arabia.

Sample Selection:

Participants were recruited using a convenience sampling approach from patients attending the College of Dentistry and the University Dental Hospital at King Abdulaziz University. Eligible participants who met the inclusion criteria were enrolled after obtaining informed parental consent.

Randomization (Sequence Generation) Random allocation sequences were generated using an online randomization tool (https://www.randomizer.org). Two sets of random numbers were created, corresponding to the two intervention orders.

Allocation Concealment:

Each allocation code was printed, cut into identical slips, and sealed in opaque envelopes. The envelopes were placed in a single container. Upon recruitment, each participant selected one envelope to determine their assigned intervention sequence.

Blinding:

Due to the nature of the interventions, blinding of the participants and operators was not feasible. However, the statistician responsible for data analysis was blinded to the group assignments to minimize analytical bias.

Inclusion and Exclusion Criteria:

The inclusion criteria included children aged 10-15 years, medically fit and systemically healthy, with no active orthodontic treatment or space maintainer with no use of any type of dental floss within the previous 24 hours. Children with fewer than four posterior proximal contacts were excluded from the study.

Sample Size Calculation:

The sample size was calculated using G*Power software (version 3.1.9.7), based on the findings of a previous study who compared the efficacy of water flossers and regular floss in plaque removal. Assuming a power of 80%, a two-tailed significance level (α) of 0.05, and an effect size derived from the cited study, a total of 44 participants (22 per group) were required to achieve sufficient statistical power.

Study Procedures:

Participants were screened according to the inclusion and exclusion criteria. Parents were informed that participation was voluntary and that all collected data would remain confidential and accessible only to the research team.

Each participant was randomly assigned to start with one of the following:

  • Regular Dental Floss: Unflavored, unwaxed regular dental floss (Oral-B, USA), or
  • Water Flosser Group: Water flosser (Waterpik Cordless Plus Water Flosser, USA).
  • both are FDA-regulated medical devices (Class I). After the first visit, a 14-day washout period was observed before the crossover intervention was applied.

At the first visit, demographic data (participant initials, age, and sex) and group allocation were recorded. A clinical examination was performed to assess the Plaque Index (PI). All participants received standardized oral hygiene instructions, including brushing twice daily with the Modified Bass Technique using a soft-bristled toothbrush and fluoridated toothpaste. Participants received instructions on the proper use of the assigned interdental cleaning method and performed the procedure independently.

The Plaque Index (PI) was recorded for all teeth according to the following criteria:

  • 0: No plaque in the gingival area.
  • 1: A film of plaque adhering to the free gingival margin and adjacent tooth area, detectable only by a probe.
  • 2: Moderate accumulation of soft deposits visible to the naked eye within the gingival margin.
  • 3: Abundant soft matter within the gingival pocket and/or along the gingival margin.

At the second visit, participants switched to the opposite cleaning method (water flosser or regular floss), and plaque scores were reassessed using the same PI criteria.

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jeddah, Saudi Arabia
        • King Abdulaziz University- Peditaric dentistry clinics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • The inclusion criteria included children aged 10-15 years, medically fit and systemically healthy, with no active orthodontic treatment or space maintainer with no use of any type of dental floss within the previous 24 hours.

Exclusion Criteria:

  • Children with fewer than four posterior proximal contacts were excluded from the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Regular Dental Floss
Unflavored, unwaxed regular dental floss (Oral-B, USA)
Plaque removal
Other Names:
  • Group A
Plaque removal
Experimental: Water Flosser
Water flosser (Cordless Plus Water Flosser, USA)
Plaque removal
Other Names:
  • Group A
Plaque removal

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plaque Index (PI)
Time Frame: 16 days, 1st visit followed by 14 days washout period then 2nd visit
to assess the Plaque Index (PI) using the criteria of Silness and Löe (1964).
16 days, 1st visit followed by 14 days washout period then 2nd visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2024

Primary Completion (Actual)

April 30, 2025

Study Completion (Actual)

April 30, 2025

Study Registration Dates

First Submitted

February 26, 2026

First Submitted That Met QC Criteria

March 9, 2026

First Posted (Actual)

March 13, 2026

Study Record Updates

Last Update Posted (Actual)

March 18, 2026

Last Update Submitted That Met QC Criteria

March 16, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Due to privacy

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Plaque Accumulation

Clinical Trials on Unflavored, unwaxed regular dental floss (Oral-B, USA)

Subscribe